Retasturtide is a recently launched novel GLP-1 receptor agonist demonstrating promising results in the treatment of type 2 diabetes. This synthetic peptide resembles the actions of naturally produced GLP-1, a hormone https://bookmarksurl.com/story6420997/retasturtide-a-novel-glp-1-receptor-agonist-for-type-2-diabetes